Background Image
Table of Contents Table of Contents
Previous Page  186 / 210 Next Page
Information
Show Menu
Previous Page 186 / 210 Next Page
Page Background

S178

Late-breaking abstracts / European Geriatric Medicine 6S1 (2015) S177

S187

22.5–24.5) had delirium and 10.5% (95% CI 9.8–11.2) had known

dementia.

Mortality was high for older adults admitted to hospital; at 30 days

after admission 14.4% (95% CI 13.5–15.3) had died and this rose to

31.9% (95% CI 30.8–33.0) at 1 year after admission. Mortality was

significantly higher for those with any cognitive spectrum disorder:

29.8% (95% CI 27.6–32.0) at 30 days after admission and 61.5%

(95% CI 59.1–63.8) at 1 year. There was no significant difference in

mortality between the individual cognitive spectrum disorders.

Conclusions:

This data allows the prevalence and mortality of the

individual cognitive spectrum disorders to be seen in context.

Delirium is more prevalent than known dementia. Undiagnosed

dementia is common. Mortality is high. The presence of any

cognitive spectrum disorder worsens prognosis.

O-094

The association between osteoarthritis and subsequent change

in weight and muscle strength

L. Schaap

1

, N. Van Schoor

2

, D. Deeg

3

1

VU University, Amsterdam, Netherlands;

2

EMGO Institute for Health

and Care Research, Dpt. of Epidemiology and Biostatistics, Amsterdam,

Netherlands;

3

VU University Medical Center, Amsterdam, Netherlands

Objectives:

Research has shown that obesity and muscle weakness

are important risk factors for osteoarthritis. However, the conse-

quences of osteoarthritis regarding changes in weight and muscle

strength are inconclusive. The aim of this study was to investigate

the association between osteoarthritis and changes in weight and

muscle strength in a European sample of older men and women.

Methods:

Data of the European Project on OSteoArthritis (EPOSA)

were used, which includes pre-harmonized data from six European

cohort studies on older community-dwelling persons aged 65–85

years. Osteoarthritis of the knee and/or hip was defined according

to the American College of Rheumatology criteria. Weight and

handgrip strength were measured at baseline and after one year

follow-up.

Results:

Men with osteoarthritis (14.6%) had a mean weight

change of −1.1% (SD 4.0) compared to −0.5% (4.0) in men without

osteoarthritis. Mean change in grip strength was −6.7% (18.9) and

−1.2% (27.3), respectively. Women with osteoarthritis (26.2%) had

a mean weight change of −0.3% (5.0) vs. −0.5% (4.4) in women

without osteoarthritis. Grip strength change was −1.4% (33.2)

and −3.0% (27.3), respectively. Linear regression analyses adjusted

for demographics, lifestyle and morbidity showed a significant

association between osteoarthritis and loss of grip strength in men

only [B −4.55 (SE 2.31), p = 0.05]. Osteoarthritis was not associated

with change in weight in both sexes.

Discussion:

Osteoarthritis of the knee and/or hip in men is

significantly associated with one-year loss of grip strength.

Osteoarthritis disease management should focus on prevention of

muscle strength loss to prevent further deterioration of physical

functioning.

O-095

Which patients benefit from orthogeriatric treatment? Results

from the Trondheim Hip Fracture Trial

I. Saltvedt

1

, A. Prestmo

2

, J. Helbostad

3

, S. Lydersen

1

, P. Thingstad

1

,

K. Taraldsen

4

, O. Sletvold

5

1

Norwegian University of Science and Technology (NTNU), Trondheim,

Norway;

2

NTNU/St. Olavs Hospital, Trondheim, Norway;

3

Department

of Neuroscience, Norwegian University of Science and Technology,

Trondheim, Norway;

4

1 Department of Neuroscience, Norwegian

University of Science and Technology, Trondheim, Norway;

5

St. Olav

University hospital and Norwegian University of Science and

Technology (NTNU), Trondheim, Norway

Objectives:

The Trondheim Hip Fracture Trial demonstrated that

comprehensive geriatric care (CGC) in a geriatric ward gave better

mobility and function as compared to traditional orthopedic care

(OC) at four months. Objectives of this study is to investigate

whether the effect of CGC depended on the subgroups of age,

gender, type of fracture, or pre-fracture function measured by

Nottingham Extended ADL scale (NEAS).

Methods:

Home-dwelling hip fracture patients

>

70 years were

randomized to receive CGC (n = 198) or OC (n = 199). Differences

between subgroups at four months were analyzed using a linear

mixed model with interactions between treatment (CGC-OC), time,

and subgroup.

Results:

Subgroup analyses showed beneficial effect of CGC on

mobility in females, intra-capsular fractures (ICF) and patients with

pre-fracture NEAS ≥45, the effect was independent of age. CGC was

beneficial for p-ADL in patients

<

80 years, females, and patients

with pre-fracture NEAS

<

45, the effect was independent of fracture

type; beneficial effect on i-ADL was found in patients

<

80 years,

females, ICF and pre-fracture NEAS ≥45, while impact on cognition

was shown for patienst with ICF.

Conclusions:

In the present post-hoc hypothesis generating study

we found that irrespective of age, gender, type of fracture or pre-

fracture i-ADL CGC was more efficient than OC in one or more

functional outcomes. The interaction analyses suggest that patients

with the best prognosis (younger patients, patients with intra-

capsular fractures and high pre-fracture function) profited most

from CGC.

O-096

Effect of nutritional supplementation and structured physical

activity on walk capacity in mobility-limited older adults:

results from the VIVE2 study

R. Fielding

1

, D. Kirn

1

, A. Koochek

2

, K. Reid

1

, A. von Berens

3

,

T. Travison

4

, H. Zhu

4

, S. Folta

5

, J. Sacheck

5

, M. Nelson

5

, C. Liu

6

,

E. Phillips

7

, A.C. Aberg

8

, M. Nydahl

9

, T. Gustafsson

10

, T. Cederholm

3

1

Jean Mayer USDA Human Nutrition Research Center on Aging at

Tufts University, Boston, United States of America;

2

Sweden;

3

Uppsala

University, Uppsala, Sweden;

4

Hebrew SeniorLife, Boston, United

States of America;

5

Friedman School of Nutrition and Policy, Tufts

University, Boston, United States of America;

6

Section of Geriatrics,

Boston University School of Medicine, Boston, United States of

America;

7

Harvard Medical School, Boston, United States of America;

8

Geriatrics, Department of Public Health and Caring Sciences, Uppsala

University, Uppsala, Sweden;

9

Department of Food, Nutrition and

Dietetics, Uppsala University, Uppsala, Sweden;

10

Department of

Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden

Objectives:

The primary objective of this study is to examine the

impact of a combined intervention of nutritional supplementation

and structured physical activity, compared to a placebo, on 400M

walk capacity in a cohort of mobility-limited older adults across

two sites (Boston, MA, USA and Stockholm, Sweden).

Methods:

Mobility-limited [Short Physical Performance Battery

(SPPB) ≤9] and vitamin D insufficient (serum 25(OH)D

≥9 & ≤24 ng/ml) older adults were recruited for this study. All

subjects participated in a physical activity program (3x/week for

24 weeks), involving walking, strength, balance, and flexibility

exercises. Subjects were randomized consume a daily nutritional

supplement (150kcal, 20g whey protein, 800IU vitamin D, 4 fl. oz.

beverage) or placebo (30kcal, non-nutritive). Primary outcome was

gait speed assessed by the 400M walk.

Results:

149 subjects were randomized into the study (mean age

77.5

±

5.4; female 46.3%; mean SPPB 7.9

±

1.2; mean vitamin D

18.7

±

6.4 ng/ml). Adherence across supplement and placebo groups

was similar for the physical activity intervention (75% and 72%,

respectively) and the study product (86% and 88%, respectively).

After the intervention period both groups demonstrated an

improvement in gait speed with no significant difference between